Search

Search Results
Results 191 - 200 of 716 for Vaccines
  • News - 8 Sep 2009
    NanoBio Corp. announced today that data from a large ferret study indicates that its intranasal, nanoemulsion-based adjuvant elicits robust immunity and cross protection against influenza using 1/15th...
  • Supplier Profile
    Our pursuit is progress for people everywhere. That's why we take a closer look at things, ask questions, and think ahead. We've been around for more than 350 years, yet our majority owners...
  • News - 1 Nov 2023
    Researchers from Northwestern Medicine have reported in ACS Nano that they have improved the process of producing vaccinations and medications using nanotherapeutics. Image Credit: ACS Nano...
  • News - 29 Mar 2013
    A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly...
  • Article - 17 Sep 2020
    MIT researchers have developed a dye, invisible to the naked eye, that has to be delivered under the skin at the time of vaccination. This dye could restore vaccination history.
  • Supplier Profile
    InProcess-LSP, headquartered in Oss at Pivot Park, is a rapidly growing, innovative company founded in 2014. Backed by a team of in-house experts—comprising physicists, chemists, and software...
  • News - 10 Jun 2024
    In a recent article published in Cell Reports, researchers from China investigated the immunodominant antibody responses induced by mosaic Receptor-binding domain (RBD) nanoparticles derived from...
  • News - 22 Dec 2021
    An exciting study could revolutionize vaccinations with a novel painless method utilizing fast-dissolving microneedles (MNs). This research has been published as a pre-proof in the International...
  • News - 6 Feb 2018
    Although cancer-fighting nanovaccines have demonstrated immense potential, their clinical application has been hindered by complexities in quality control, large-scale manufacturing, and protection....
  • News - 19 Feb 2010
    Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that Frank J. Malinoski, M.D., Ph.D., has joined the company as...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.